Posted by Michael Wonder on 30 Jun 2018
Schedule of Pharmaceutical Benefits - 1 July 2018 update
1 July 2018 - The July 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The July issue of the Schedule includes a number of new/revised listings:
- Adrenaline (Emerade) - new formulation
- Infliximab (Renflexis) - restriction change
- Ribociclib succinate (Kisqali) - new medicine
